Intravenous sodium bicarbonate administration does not reduce 90-day all-cause mortality in critically ill patients with ...
After that, I'll come back with a few comments on how we evaluate our performance year to date, where we are in our mission ...
GC Biopharma USA, Inc., a leader in plasma-derived products, announced today its support of data analysis and publication of the 2025 Immunoglobulin National Society (IgNS) Patient 360 Longitudinal ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...
From a sprawling 5000-square-metre sanctuary focused on gut health, to a popular UK spa’s Aussie debut, these spots are worth ...
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, ...
Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics - ...
A histology showing the ankle joint of a mouse four days after receiving the new antibody treatment, V11 sFc (Ravetch lab) Intravenous immunoglobulin ...
It was about 10.30am, an average Wednesday two and a bit weeks ago, when my usually sparky, chatty, bright and switched-on ...
Viridian Therapeutics, Inc. nears profitability and gears up for veligrotug’s 2025 launch. Click here to find out why VRDN ...
(“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FDA-cleared drug-delivery device, ...
PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback